An evidence-based approach to writing reviews as illustrated by treatment of erectile dysfunction
- Authors: Apolikhin OI1, Abdullin II1
-
Affiliations:
- Issue: No 5 (2005)
- Pages: 31-35
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/276624
- ID: 276624
Cite item
Full Text
Abstract
Reviews integrate the data from original sources of information on the given topic. The quality of the review of literature depends on the quality of initial information. The development of evidencebased medicine demands higher standards from clinical trials. The authors analyse available information on the treatment of erectile dysfunction basing on standard international requirements for clinical trials. A checking list is available for standardization of clinical assessment. The data obtained is ranged by the degree of statistical significance. Basing on the evidence-based approach, the conclusion on efficacy of the following modern drugs in the treatment of erectile dysfunction are made: sildenafil, iochimbin, prostaglandin El and tadalafil. The conclusion on efficacy of the other drags against erectile dysfunction is impossible in view of methodological drawbacks of the trials.
References
- NIH consensus development panel on impotence: impotence. У А. М. A. 1995; 270: 83-90.
- MkKinlay J. B. The worldwilde prevalance and epidemiology of erectile dysfunction. Int. J. Impotence. Res. 2000; 12 (suppl. 4): S6-SU.
- Feldman H. A., Goldstein I. et al. Impotence and its medical and psychological correlates: results of Massachusetts Male Aging Study. J. Urol. (Baltimore) 1994; 151: 54-61.
- Jackson G., Betteridge J., Dean J. et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int. J. Clin. Pract. 1999; 53: 445-451.
- Benet A. E., Melman A. The epidemiology of erectile dysfunction. Urol. Clin. N. Am. 1995; 2: 699-709.
- Derby C. A., Mohr B. A., Goldstein I. et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302-306.
- Shah J. Erectile dysfunction through the ages. Br. J. Urol. Int. 2002; 4: 90-94.
- Власов В. В. Введение в доказательную медицину. М.: Медиа Сфера; 2001.
- Аполихин О. И., Абдулшн И. И. Необходимость использования доказательной медицины в принятии клинических решений на примере эректильной дисфункции. Урология 2003; 3: 3-7.
- Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины: Пер. с англ. М.: Медиа Сфера; 1998.
- Greenhalgh Т. How to read a paper. The basics of evidance based medicine. 2-nd ed. BMJ Books: 2001.
- www.consort-statement.org
- www.cochrane.org
- www.clinicalevidence.org
- www.nlm.nih.gov
- Brock G. В., McMahon С. G., Chen К. К. et al. Efficacy and safety of tadalaffl for the treatment of erectile dysfunction: results of integrated analyses. J. Urol. (Baltimore) 2002; 168 (4, pt 1): 1332-1336.
- Ковалев В. А., Королева С. В. Опыт применения простагландина Е, (Эдекс, Каверджект) для диагностики и лечения эректильной дисфункции. Урол. и нефрол. 1997; 2: 41-44.
- Тиктинский О. Л., Калинина С. Н., Зубовский К. Ю. Роль тестостерона андеканоата в коррекции нарушений копулятивной функции. Урол. и нефрол. 1996; 5: 47-48.
- Гориловский Л. М. Интракавернозное введение "Эдекса" (простагландина Е,) в лечении эректильной импотенции у лиц старших возрастных групп. Урол. и нефрол. 2002; 6: 31-33.
- Терек А., Секеи Й., Гетц Ф. Индуцирование эрекции с помощью папаверина. Урол. и нефрол. 1989; 3: 69-71.
- www.uroweb.org
Supplementary files
